Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Lymphoid 1

Conditions

Multiple Myeloma 2Neoplasms, Plasma Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1

Interventions

Cyclophosphamide 20fludarabine phosphate 14Peripheral Blood Stem Cell Transplantation 13Dexamethasone 13Cyclosporine 12Whole-Body Irradiation 11fludarabine 10Exercise 10Antilymphocyte Serum 10Melphalan 9Busulfan 9Blood Specimen Collection 9Mycophenolic Acid 8Therapeutics 7Filgrastim 7Bortezomib 7Standard of Care 6Radiotherapy 6Behavior Therapy 6Acupuncture Therapy 6pomalidomide 5Specimen Handling 5Palliative Care 5Methotrexate 5Granulocyte Colony-Stimulating Factor 5Etoposide 5Educational Status 5daratumumab 4Surveys and Questionnaires 4Stem Cell Transplantation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Heptavalent Pneumococcal Conjugate Vaccine × Plasma cell × Clear all
NCT00569309 2018-03-12

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma

Ohio State University Comprehensive Cancer Center

Phase NA Completed
30 enrolled 8 charts
LymphoidPlasma cell

Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell

NCT01852591 2017-02-02

PCV13

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
8 enrolled 10 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡